These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9359955)

  • 1. Effects of ingredients on stability of captopril in extemporaneously prepared oral liquids.
    Lye MY; Yow KL; Lim LY; Chan SY; Chan E; Ho PC
    Am J Health Syst Pharm; 1997 Nov; 54(21):2483-7. PubMed ID: 9359955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term stability of extemporaneously prepared captopril oral liquids in glass bottles.
    Brustugun J; Lao YE; Fagernaes C; Braenden J; Kristensen S
    Am J Health Syst Pharm; 2009 Oct; 66(19):1722-5. PubMed ID: 19767378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stability study of an aqueous formulation of captopril at 1 mg/ml].
    Escribano García MJ; Torrado Durán S; Torrado Durán JJ
    Farm Hosp; 2005; 29(1):30-6. PubMed ID: 15773800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation.
    Pabari RM; McDermott C; Barlow J; Ramtoola Z
    Clin Ther; 2012 Nov; 34(11):2221-9. PubMed ID: 23149007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of captopril in some aqueous systems.
    Pramar Y; Das Gupta V; Bethea C
    J Clin Pharm Ther; 1992 Jun; 17(3):185-9. PubMed ID: 1639881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1996 Sep; 53(18):2179-84. PubMed ID: 8879325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term stability of atenolol in oral liquid formulations.
    Patel D; Doshi DH; Desai A
    Int J Pharm Compd; 1997; 1(6):437-9. PubMed ID: 23989440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of ursodiol 25 mg/mL in an extemporaneously prepared oral liquid.
    Mallett MS; Hagan RL; Peters DA
    Am J Health Syst Pharm; 1997 Jun; 54(12):1401-4. PubMed ID: 9194984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sucrose, citric buffer and glucose oxidase on the stability of captopril in liquid formulations.
    Liu J; Chan SY; Ho PC
    J Clin Pharm Ther; 1999 Apr; 24(2):145-50. PubMed ID: 10380067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of procainamide hydrochloride in an extemporaneously compounded oral liquid.
    Metras JI; Swenson CF; McDermott MP
    Am J Hosp Pharm; 1992 Jul; 49(7):1720-4. PubMed ID: 1621730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of sulfadiazine oral liquids prepared from tablets and powder.
    Pathmanathan U; Halgrain D; Chiadmi F; Schlatter J; Vermerie N
    J Pharm Pharm Sci; 2004 Apr; 7(1):84-7. PubMed ID: 15144740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of an extemporaneously compounded clonidine hydrochloride oral liquid.
    Levinson ML; Johnson CE
    Am J Hosp Pharm; 1992 Jan; 49(1):122-5. PubMed ID: 1570852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of amlodipine besylate in two liquid dosage forms.
    Nahata MC; Morosco RS; Hipple TF
    J Am Pharm Assoc (Wash); 1999; 39(3):375-7. PubMed ID: 10363465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of famotidine in an extemporaneously prepared oral liquid.
    Quercia RA; Jay GT; Fan C; Chow MS
    Am J Hosp Pharm; 1993 Apr; 50(4):691-3. PubMed ID: 8470686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of propylthiouracil in extemporaneously prepared oral suspensions at 4 and 25 degrees C.
    Nahata MC; Morosco RS; Trowbridge JM
    Am J Health Syst Pharm; 2000 Jun; 57(12):1141-3. PubMed ID: 10911513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1996 Sep; 53(17):2073-8. PubMed ID: 8870895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of captopril in invert sugar solution.
    Sam WJ; Ho PC
    J Clin Pharm Ther; 1998 Dec; 23(6):451-6. PubMed ID: 10048506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of acetylcysteine in an extemporaneously compounded ophthalmic solution.
    Anaizi NH; Swenson CF; Dentinger PJ
    Am J Health Syst Pharm; 1997 Mar; 54(5):549-53. PubMed ID: 9066864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of rifabutin in two extemporaneously compounded oral liquids.
    Haslam JL; Egodage KL; Chen Y; Rajewski RA; Stella V
    Am J Health Syst Pharm; 1999 Feb; 56(4):333-6. PubMed ID: 10690216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.